CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- 4 Planned sale Director sold 25,000 shares at $10.75 ($268,760)
- 4 Planned sale Director sold 81,056 shares at $10.50 ($851,088)
- 4 Planned sale Director sold 131,210 shares at $9.50 ($1,246,941)
- 4 Planned sale Director sold 159,478 shares at $9.02 ($1,439,066)
- 4 Planned sale Director sold 96,722 shares at an average $9.01 ($871,216)
- 4 Planned sale Director sold 25,000 shares at $7.88 ($196,908)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 23,033 shares at $7.18 ($165,306)
- 4 Conversion See remarks acquired 4,606,596 shares (conversion)
- 4 Planned sale Director sold 75,000 shares at $12.01 ($900,788)
- 4 Planned sale Director sold 25,000 shares at $10.00 ($250,000)
- 4 Shares withheld for taxes Chief Financial Officer gave up 20,682 shares (to pay taxes)
- 4 Shares withheld for taxes See remarks gave up 58,170 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 1,673 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President gave up 77,560 shares (to pay taxes)
Page 1 of 13 · 251 filings